Experience summary of Li Liangquan in treating chronic diseases with modified Siwu Decoction
WANG Yue1 ZOU Xinrong1，2，3▲
1.Clinical College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430061, China;
2.Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province, Wuhan 430061, China;
3.Hubei Province Academy of Traditional Chinese Medicine, Hubei Province, Wuhan 430074, China
Abstract：Professor Li Liangquan, deputy chief physician of Nephrology Department of Hubei Provincial Hospital of Traditional Chinese Medicine, has been engaged in the clinical work of traditional Chinese medicine in the prevention and treatment of nephropathy for more than 30 years, and he has rich experience in diagnosis and treatment of common clinical nephropathy and other diseases. Professor Li Liangquan considers that chronic diseases are often deficient, and chronic diseases or complicated diseases are closely related to blood stasis and blood deficiency. Professor Li Liangquan believes that Siwu Decoction can be used as the basic prescription for the treatment of chronic diseases, and it is effective in clinical practice for many years. Many modern clinical controlled trials and animal experiments have also proved that Siwu Decoction has a good prognosis for a series of chronic diseases. On the basis of Siwu Decoction, Professor Li Liangquan uses it widely in clinical diseases. In this paper, Professor Li Liangquan’s common prescriptions for six common diseases, including chronic nephritis, spermatorrhea, urinary tract infection, low back pain and alopecia in elderly women, are cited, as well as the traditional Chinese medicine added or subtracted accordingly, as well as an example of a case, so as to provide reference for the people engaged in the same pursuit.
王悦1 邹新蓉1,2,3▲. 李良泉活用四物汤加味治疗慢性病的经验总结[J]. 中国医药导报, 2021, 18(18): 140-142,150.
WANG Yue1 ZOU Xinrong1，2，3▲. Experience summary of Li Liangquan in treating chronic diseases with modified Siwu Decoction. 中国医药导报, 2021, 18(18): 140-142,150.
京公网安备 11010502046598号